Inhibitory effect of tetrahydrocurcumin on dimethylnitrosamine-induced liver fibrosis in rats
Authors:
- Shu-Chen HsiehSHShu-Chen Hsieh
- Vladimir BadmaevVBVladimir Badmaev
- Min-Hsiung PanMin-Hsiung Pan
- 1 March 2014
- journal article
- Published by Elsevier in Journal of Functional Foods
- Vol. 7, 305-313
Abstract
No abstract availableKeywords
Funding Information
- National Science Council NSC (101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3, qNTU-103R7777)
This publication has 29 references indexed in Scilit:
- TGF-β1-induced epithelial–mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in Human A549 lung cancer cellsCancer Letters, 2013
- E-Cadherin Antagonizes Transforming Growth Factor β1 Gene Induction in Hepatic Stellate Cells by Inhibiting RhoA–Dependent Smad3 PhosphorylationHepatology, 2010
- Curcumin as a therapeutic agent: the evidence fromin vitro, animal and human studiesBritish Journal of Nutrition, 2010
- Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends in Pharmacological Sciences, 2009
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre‐disposition pending between fiction and realityJournal of Cellular and Molecular Medicine, 2007
- Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagenToxicology, 2001
- Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamineClinical Biochemistry, 2000
- Glycoprotein metabolism in dimethyinitrosan ne induced hepatic fibrosis in ratsThe International Journal of Biochemistry & Cell Biology, 1996
- The Metabolism and Excretion of Curcumin (1,7-Bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the RatXenobiotica, 1978